Paul Tudor Jones’s Medicines Co MDCO Stock Holding History

Paul Tudor Jones’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-9,404	Closed	-$257K	–	1364
2017 Q4	$257K	Buy	+9,404	New	+$290K	0.01%	877
2017 Q3	–	Sell	-8,812	Closed	-$335K	–	1330
2017 Q2	$335K	Buy	+8,812	New	+$392K	0.01%	729
2015 Q2	–	Sell	-9,000	Closed	-$252K	–	1751
2015 Q1	$252K	Buy	+9,000	New	+$253K	0.01%	1156
2013 Q4	–	Sell	-7,300	Closed	-$245K	–	1398
2013 Q3	$245K	Sell	7,300 -3,800	-34%	-$121K	0.01%	670
2013 Q2	$341K	Buy	+11,100	New	+$371K	0.03%	495

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Bridger Management New York $150M AUM 17.71% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Paul Tudor Jones's MDCO Position: Q1 2018 in Review

Paul Tudor Jones sold out of Medicines Co (MDCO) in Q1 2018, closing a stake of 9,404 shares — an estimated $257K sold.

Paul Tudor Jones first reported a position in MDCO in Q2 2013 and held it in 5 quarters. The position peaked at $341K in Q2 2013. 190 funds tracked by Wall St. Rank hold MDCO as of Q1 2018.

Paul Tudor Jones reported no remaining Medicines Co position as of Q1 2018 after selling out during the quarter.
Paul Tudor Jones sold 9,404 Medicines Co shares in Q1 2018, an estimated $257K.
Paul Tudor Jones first reported a position in Medicines Co in Q2 2013 and held it in 5 quarters.
Paul Tudor Jones's Medicines Co position peaked at $341K in Q2 2013.
190 funds tracked by Wall St. Rank held Medicines Co as of Q1 2018.

Based on Tudor Investment Corp's 13F filing for Q1 2018, filed 15 May 2018.